CD209 and HIV-1 infection: We have shown here that BmA can potently bind DC-SIGN and block HIV-1 trans-infection of CD4+ enriched T-cells and thereby potentially play a role in modulating HIV-1 infection or replication in exposed or infected individuals, respectively.